| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 07/06/2011 | CN101048408B Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 07/05/2011 | CA2446136C Pyruvate derivatives |
| 06/30/2011 | WO2011078143A1 Pyrimidine derivatives and pharmaceutical composition containing same |
| 06/30/2011 | WO2010110685A4 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |
| 06/30/2011 | US20110160229 Ahcy hydrolase inhibitors for treatment of hyper homocysteinemia |
| 06/30/2011 | US20110160228 Dihydro-iso-ca-4 and analogues: potent cytotoxics, inhibitors of tubulin polymerization |
| 06/30/2011 | US20110160162 Prodrugs of a2b adenosine receptor antagonists |
| 06/29/2011 | CN102112477A 6-(c2-6alkylseleno) purines and methods for treating neural measles viral infection therewith |
| 06/29/2011 | CN101602764B Method for preparing acyclovir 2/3 hydrate |
| 06/28/2011 | US7968556 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 06/28/2011 | US7968555 Intermediates in the preparation of entecavir via carbon-silicon oxidation |
| 06/28/2011 | US7968544 Modulators of toll-like receptor 7 |
| 06/28/2011 | CA2479039C 2,2-bis(hydroxymethyl)cyclopropylidenemethyl -purines and -pyrimidines as antiviral agents |
| 06/28/2011 | CA2322008C 2'-fluoronucleosides |
| 06/23/2011 | WO2011075630A1 Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors |
| 06/23/2011 | US20110152282 Hedgehog pathway modulators |
| 06/23/2011 | US20110152277 Heterocyclic compounds and their uses |
| 06/23/2011 | US20110152242 2,3-Substituted Fused Pyrimidin -4 (3H)-Ones as VR1 Antagonists |
| 06/22/2011 | EP2336133A1 Purine analogs having HSP90-inhibiting activity |
| 06/22/2011 | EP2336132A1 Morpholinopurine derivative |
| 06/22/2011 | EP1812004B1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors |
| 06/22/2011 | CN102105474A Purine PI3K inhibitor compounds and methods of use |
| 06/22/2011 | CN101239980B Immunity receptor regulator couplet precursor, couplet and application thereof |
| 06/22/2011 | CN101031569B Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 06/16/2011 | WO2011069294A1 N6-substituted adenosine derivatives, n6-substituted adenine derivatives and uses thereof |
| 06/16/2011 | US20110144332 Pyrazole compounds that modulate hsp90 activity |
| 06/16/2011 | US20110144136 Novel adenine derivatives |
| 06/16/2011 | US20110144095 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 06/16/2011 | US20110144083 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions |
| 06/16/2011 | US20110144070 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 06/16/2011 | CA2783859A1 N6-substituted adenosine derivatives and n6-substituted adenine derivatives and uses thereof |
| 06/15/2011 | EP2332941A2 Stabilized solid dispersion of adefovir dipivoxil and preparation method thereof |
| 06/15/2011 | EP2332541A1 Use of thioxanthine derivatives as MPO inhibitors |
| 06/15/2011 | EP2331543A1 3-deazaneplanocin derivatives |
| 06/15/2011 | EP2331542A2 A3 adenosine receptor antagonists and partial agonists |
| 06/15/2011 | EP2331510A1 Novel substrates of o6-alkylguanine-dna alkyltransferase and mutants thereof |
| 06/15/2011 | EP2330908A1 Fluorescent cdk inhibitors for treatment of cancer |
| 06/14/2011 | US7960397 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions |
| 06/09/2011 | WO2011068978A1 Methanocarba adenosine derivatives and dendrimer conjugates thereof |
| 06/09/2011 | US20110136834 Inhibitors of e1 activating enzymes |
| 06/09/2011 | US20110136767 Processes for preparing piperazinium salts of kmup and use thereof |
| 06/09/2011 | US20110135671 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 06/09/2011 | US20110135670 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 06/08/2011 | EP2330107A2 Improved production method for adefovir dipivoxil |
| 06/08/2011 | EP2328897A1 Bicyclic heterocycle derivatives and their use as gpcr modulators |
| 06/08/2011 | EP2328871A2 Hedgehog pathway modulators |
| 06/08/2011 | EP2044054B1 Pyrimidine and quinazoline derivatives as modulators of somatostatine receptor activity |
| 06/08/2011 | CN102089308A PI3K isoform selective inhibitors |
| 06/08/2011 | CN102089279A Biaryl PDE4 inhibitors for treating inflammation |
| 06/08/2011 | CN101130543B Process for preparing the antiviral agent [1s-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6h-purin-6-one |
| 06/07/2011 | CA2339967C Structural analogs of amine bases and nucleosides |
| 06/03/2011 | WO2011064793A1 Process for the preparation of amorphous valganciclovir hydrochloride |
| 06/03/2011 | WO2006119507A3 Non-nucleotide composition and method for inhibiting platelet aggregation |
| 06/02/2011 | US20110130559 Methods to Manufacture 1,3-Dioxolane Nucleosides |
| 06/02/2011 | US20110130549 Method for the treatment of amyloidoses |
| 06/02/2011 | US20110130397 Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereof |
| 06/02/2011 | US20110130395 P13k isoform selective inhibitors |
| 06/02/2011 | US20110130381 Small molecule inhibitors of plasmodium falciparum dihydroorotate dehydrogenase |
| 06/02/2011 | US20110130362 A2b adenosine receptor antagonists |
| 06/02/2011 | US20110130285 Composition for promoting root nodule formation of plants and a method for promoting root nodule formation of plants |
| 06/01/2011 | EP2326647A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazoioý4,5- c¨pyridinyl)purine and purinone derivatives for immunosuppression |
| 06/01/2011 | EP2326646A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 06/01/2011 | CN101314603B Valine protected imidazo-[1,2-a] purine three-loop base opened-loop nucleoside compounds, preparation method and application thereof |
| 05/31/2011 | US7951820 Triazole compounds useful as protein kinase inhibitors |
| 05/31/2011 | US7951803 8-heteroarylpurine MNK2 inhibitors for treating metabolic disorders |
| 05/31/2011 | US7951592 Compositions and methods for inducing cell dedifferentiation |
| 05/31/2011 | CA2319080C Multivalent antibacterial agents |
| 05/26/2011 | US20110124832 novel living radical polymerization method using alcohol as catalyst |
| 05/25/2011 | EP2324843A1 Use of TNF-alpha inhibitors for treating nerve root injury |
| 05/25/2011 | EP2324026A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 05/25/2011 | EP2324025A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 05/25/2011 | CN1578663B Inhibitors of histone deacetylase |
| 05/25/2011 | CN102076688A Purine derivatives further comprising a mercapto-acylamino group as neutral endopeptidase inhibitors |
| 05/25/2011 | CN102070636A Preparation method of penciclovir |
| 05/25/2011 | CN102070635A Preparation method for ganciclovir valine ester derivative |
| 05/25/2011 | CN101062037B Process for their preparation of thioxanthine derivatives, their use |
| 05/24/2011 | CA2645967C Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 05/19/2011 | WO2011058113A1 Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors |
| 05/19/2011 | WO2011058111A1 Aminopurine derivatives as kinase inhibitors |
| 05/19/2011 | WO2011058025A1 N-7 substituted purine and pyrazolopyrimidine compounds, compositions and methods of use |
| 05/19/2011 | WO2011019752A3 A1 adenosine receptor agonist polymorphs |
| 05/19/2011 | US20110118464 Halogenated xanthine derivatives and precursors thereof for anti-cancer and anti-metastasis activity and preparing method thereof |
| 05/19/2011 | US20110118257 Novel kinase modulators |
| 05/19/2011 | US20110118238 2-anilinopurin-8-ones as inhibitors of ttk/mps1 for the treatment of proliferative disorders |
| 05/19/2011 | US20110118219 Novel prodrugs of c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity |
| 05/19/2011 | CA2781056A1 Kinase inhibitors |
| 05/19/2011 | CA2780018A1 N-7 substituted purine and pyrazolopyrimidine compounds, compositions and methods of use |
| 05/19/2011 | CA2778686A1 N-9-substituted purine compounds, compositions and methods of use |
| 05/18/2011 | EP2322525A1 Purine derivatives for use as adenosin A2A receptor agonists |
| 05/18/2011 | EP2322518A1 Method of manufacture of 1,3-dioxolane and 1,3-oxathiolane nucleosides |
| 05/18/2011 | EP2320905A1 Novel adenine derivatives |
| 05/18/2011 | CN102066338A Inhibitors of protein kinases |
| 05/18/2011 | CN102060782A Method for preparing chloropyrimidines or analogues thereof |
| 05/18/2011 | CN101407517B Preparation of ambroxol theophylline-7-acetate |
| 05/17/2011 | US7943625 2 thioxanthine derivatives acting as MPO-inhibitors |
| 05/12/2011 | WO2011055391A1 Substituted fused pyrimidine compounds, its preparation and uses thereof |
| 05/12/2011 | WO2011018771A3 Process for the preparation of valganciclovir hydrochloride |
| 05/12/2011 | WO2010151735A3 4h - pyrido [ 1, 2 - a] pyrimidin - 4 - one derivatives as pi3 k inhibitors |
| 05/12/2011 | US20110112058 Novel modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| 05/11/2011 | EP2319856A1 Methods and compositions for treating hepatitis c virus |